Announcements Trials
Browse Landscape

Phase

Phase 2 91Phase 1 64Phase 1/2 38Phase 3 31Phase NA 2Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Unknown 3Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Lung Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Large Cell 1Carcinoma 1Adenocarcinoma Pancreas 1Adenocarcinoma 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × 130-nm albumin-bound paclitaxel × Clear all
NCT02812992 2021-08-10

GrantPax

AIO-Studien-gGmbH

Phase 4 Completed
32 enrolled
Gastrointestinal

Adenocarcinoma Pancreas

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡